Non-Hodgkin Lymphoma Following Temozolomide

被引：11
|
作者：
Sharma, Atul [1 ]
Gupta, Deepak [1 ]
Mohanti, B. K. [2 ]
Thulkar, Sanjay [3 ]
Dwary, Amit [1 ]
Goyal, Shikha [2 ]
Muzumder, Sandeep [2 ]
Das, Prasenjit [4 ]
机构：
[1] All India Inst Med Sci, Dr BRA IRCH, Dept Med Oncol, New Delhi 110029, India
[2] All India Inst Med Sci, Dr BRA IRCH, Dept Radiat Oncol, New Delhi 110029, India
[3] All India Inst Med Sci, Dr BRA IRCH, Dept Radiodiag, New Delhi 110029, India
[4] All India Inst Med Sci, Dr BRA IRCH, Dept Pathol, New Delhi 110029, India
来源：
PEDIATRIC BLOOD & CANCER | 2009年 / 53卷 / 04期
关键词：
glioblastoma multiforme; temozolomide; second malignancy; non-Hodgkin lymphoma;
D O I：
10.1002/pbc.22090
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Temozolomide (TMZ) is an oral alkylating agent with significant activity against glioblastoma multiforme (GBM) and melanoma. It increases survival by 2.5 months when used in combination with radiotherapy as an adjuvant therapy in GBM. Secondary MDS/AML or non-Hodgkin lymphoma attributed to TMZ exposure has been reported. We report a case of non-Hodgkin lymphoma secondary to temozolomide in a 20-year-old female who was treated for GBM with concurrent TMZ and radiotherapy. She developed lymphoma 2 months after completing chemoradiotherapy. Although she was treated with combination chemotherapy for lymphoma, she died of progressive GBM. Pediatr Blood Cancer 2009;53: 661-662. (C) 2009 Wiley-Lis, Inc.
引用
收藏
页码：661 / 662
页数：2
相关论文
共 50 条
  • [41] Alcohol consumption and non-Hodgkin lymphoma survival
    Han, Xuesong
    Zheng, Tongzhang
    Foss, Francine M.
    Ma, Shuangge
    Holford, Theodore R.
    Boyle, Peter
    Leaderer, Brian
    Zhao, Ping
    Dai, Min
    Zhang, Yawei
    JOURNAL OF CANCER SURVIVORSHIP, 2010, 4 (02) : 101 - 109
  • [42] Meat intake and risk of non-Hodgkin lymphoma
    Briseis Aschebrook-Kilfoy
    Nicholas J. Ollberding
    Carol Kolar
    Terence A. Lawson
    Sonali M. Smith
    Dennis D. Weisenburger
    Brian C.-H. Chiu
    Cancer Causes & Control, 2012, 23 : 1681 - 1692
  • [43] Noncellular Immune Therapies for Non-Hodgkin Lymphoma
    Herrera, Alex F.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2019, 33 (04) : 707 - +
  • [44] Non-Hodgkin Lymphoma in a Patient With Cardiofaciocutaneous Syndrome
    Ohtake, Akira
    Aoki, Yoko
    Saito, Yuka
    Niihori, Tetsuya
    Shibuya, Atsushi
    Kure, Shigeo
    Matsubara, Yoichi
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2011, 33 (08) : E342 - E346
  • [45] A CASE OF PRIMARY NON-HODGKIN LYMPHOMA OF THE PANCREAS
    JOLY, I
    DAVID, A
    PAYAN, MJ
    SAHEL, J
    SARLES, H
    PANCREAS, 1992, 7 (01) : 118 - 120
  • [46] Molecular genetics related to non-Hodgkin lymphoma
    Guo, Ming
    Mao, Xianglin
    Ding, Xiaoqing
    OPEN LIFE SCIENCES, 2016, 11 (01): : 86 - 90
  • [47] The evolving role of lenalidomide in non-Hodgkin lymphoma
    Galanina, Natalie
    Petrich, Adam
    Nabhan, Chadi
    LEUKEMIA & LYMPHOMA, 2016, 57 (07) : 1507 - 1516
  • [48] Advances and application of radioimmunotherapy in non-Hodgkin lymphoma
    Stevens, Patrick L.
    Oluwole, Olalekan
    Reddy, Nishitha
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2012, 2 (02): : 86 - 97
  • [49] The Experience of Illness in Non-Hodgkin Lymphoma Patients
    Kim, Hye Sook
    Yi, Myungsun
    ASIAN ONCOLOGY NURSING, 2016, 16 (03) : 121 - 131
  • [50] CYTOGENETIC CHARACTERISTICS OF CHILDHOOD NON-HODGKIN LYMPHOMA
    SHIKANO, T
    ISHIKAWA, Y
    NAITO, H
    KOBAYASHI, R
    NAKADATE, H
    HATAE, Y
    TAKEDA, T
    CANCER, 1992, 70 (03) : 714 - 719
12345